Skip to main content
. 2022 Aug 1;11(15):2367. doi: 10.3390/cells11152367

Figure 4.

Figure 4

(A–I) Increased expression of COX-2 in Pre-T2D IPFP-ASCs compared to Non-T2D and T2D IPFP-ASCs before and after IL-1β treatment. (n = 3, * p < 0.05, ** p < 0.01, *** p < 0.001). Non-T2D: Non-Type II diabetes mellitus, Pre-T2D: Pre-Type II diabetes mellitus, T2D: Type II diabetes mellitus.